Live Breaking News & Updates on Squarex pharma

Stay informed with the latest breaking news from Squarex pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Squarex pharma and stay connected to the pulse of your community

Genital Herpes Pipeline Landscape: Insights into Emerging Therapies, Growth Variables, Commercial Assessment and Key Pharmaceutical Companies Active in the Space - Press Release

25+ active players in the domain working on 25+ pipeline therapies.
Key Genital Herpes pipeline therapies such as
HSV 2 Vaccines, RVx-201, NE HSV-2 Vaccine, HDIT 101, Pritelivir, UB-621, and others are under investigation in different phases of clinical trials for the treatment of Genital Herpes.
Sanofi, Rational Vaccines, BlueWillow Biologics, Heidelberg, ImmunoTherapeutics, AiCuris, United Biopharma, among several others, are some of the key prominent pharma players working in the domain.
In
May 2021, X-Vax Technology announced that it is preparing to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its experimental vaccine against herpes simplex virus 1 and 2 (HSV-1 and -2).

United-states , Bluewillow-biologics , Los-angeles , Heidelberg-immunotherapeutics , Evofem-biosciences , Squarex-pharma , Key-pharmaceutical-companies , Key-genital-herpes-companies , Drug-administration , Delveinsight-due-diligence-services , Key-companies , Johnson